Venk is the co-founder and Chief Executive Officer of Nanowear, a New York-based connected-self technology platform for non-invasive diagnostics and chronic disease management built on proprietary, patented cloth-based nanosensors; the first-and-only cloth based sensor technology that has received Class II FDA 510(k) for remote cardiac monitoring. Founded in 2014, Nanowear’s first product (SimpleSense) is an undergarment for Congestive Heart Failure digital alert monitoring which will be clinically validated in the upcoming multi-site NanoSense clinical trial.
Before Nanowear, Venk Varadan spent ~7 years in Technology Investment Banking, focusing exclusively on venture-backed software and communications technology in which he successfully advised growth companies in over $3bn USD worth of transactions at UBS Investment Bank, Citadel Investment Group and Wells Fargo Securities in New York. Prior to his Wall Street career, Venk spent ~ 3 years in sales and marketing at Eli Lilly and Sanofi Aventis Pharmaceuticals in New York.
Venk received his Masters of Business Administration from Columbia University in Finance & Entrepreneurship and his Bachelor of Science in Biochemistry from Duke University
Join Venk to hear about Nanowear’s journey from receiving FDA 510(k) clearance for SimpleSense, its remote congestive heart failure monitoring technology, to a manufacturing partnership with The Secant Group and commercialization strategy development and execution.
Check out the incredible speaker line-up to see who will be joining Venk.